0.4111
price down icon2.12%   -0.0089
after-market After Hours: .45 0.0389 +9.46%
loading
Shuttle Pharmaceuticals Holdings Inc stock is traded at $0.4111, with a volume of 88,737. It is down -2.12% in the last 24 hours and down -35.60% over the past month. Shuttle Pharmaceuticals Holdings Inc is a clinical-stage pharmaceutical company leveraging its proprietary technology to develop novel therapies designed to cure cancers. The company's goal is to extend the benefits of cancer treatments with surgery, radiation therapy, chemotherapy and immunotherapy. Radiation therapy (RT) is one of the effective modalities for treating cancers. It is developing a pipeline of products designed to address the limitations of the current cancer therapies as well as to extend to the new applications of RT. The company believes that its product candidates will enable the company to deliver cancer treatments that are safer, more reliable and at a greater scale than that of the current standard of care.
See More
Previous Close:
$0.42
Open:
$0.42
24h Volume:
88,737
Relative Volume:
0.64
Market Cap:
$2.02M
Revenue:
-
Net Income/Loss:
$-7.35M
P/E Ratio:
-0.8937
EPS:
-0.46
Net Cash Flow:
$-5.48M
1W Performance:
-5.58%
1M Performance:
-35.60%
6M Performance:
-74.62%
1Y Performance:
-5.69%
1-Day Range:
Value
$0.391
$0.4323
1-Week Range:
Value
$0.331
$0.485
52-Week Range:
Value
$0.2872
$3.30

Shuttle Pharmaceuticals Holdings Inc Stock (SHPH) Company Profile

Name
Name
Shuttle Pharmaceuticals Holdings Inc
Name
Phone
(240) 403-4212
Name
Address
401 PROFESSIONAL DRIVE, GAITHERSBURG
Name
Employee
9
Name
Twitter
Name
Next Earnings Date
Name
Latest SEC Filings
Name
SHPH's Discussions on Twitter

Compare SHPH with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Drug Manufacturers - Specialty & Generic icon
SHPH
Shuttle Pharmaceuticals Holdings Inc
0.4111 2.02M 0 -7.35M -5.48M -0.46
Drug Manufacturers - Specialty & Generic icon
ZTS
Zoetis Inc
163.75 73.33B 9.26B 2.49B 2.30B 5.47
Drug Manufacturers - Specialty & Generic icon
TAK
Takeda Pharmaceutical Co Adr
15.13 47.80B 30.25B 1.37B 5.08B 0.4257
Drug Manufacturers - Specialty & Generic icon
HLN
Haleon Plc Adr
10.37 46.89B 14.35B 1.85B 0 0.4023
Drug Manufacturers - Specialty & Generic icon
TEVA
Teva Pharmaceutical Industries Ltd Adr
16.29 18.67B 16.54B -1.64B 749.00M -1.45
Drug Manufacturers - Specialty & Generic icon
ITCI
Intra Cellular Therapies Inc
131.53 13.99B 612.78M -86.37M -62.91M -0.87

Shuttle Pharmaceuticals Holdings Inc Stock (SHPH) Latest News

pulisher
Mar 19, 2025

12 Health Care Stocks Moving In Wednesday's After-Market Session - Benzinga

Mar 19, 2025
pulisher
Mar 17, 2025

SHPH stock touches 52-week low at $0.34 amid market challenges By Investing.com - Investing.com South Africa

Mar 17, 2025
pulisher
Mar 17, 2025

SHPH stock touches 52-week low at $0.34 amid market challenges - Investing.com India

Mar 17, 2025
pulisher
Mar 17, 2025

12 Health Care Stocks Moving In Monday's Pre-Market Session - Benzinga

Mar 17, 2025
pulisher
Mar 14, 2025

12 Health Care Stocks Moving In Friday's After-Market Session - Benzinga

Mar 14, 2025
pulisher
Mar 14, 2025

12 Health Care Stocks Moving In Friday's Pre-Market Session - Benzinga

Mar 14, 2025
pulisher
Mar 14, 2025

SHPHSHUTTLE PHARMACTCLS HLDGS INC Latest Stock News & Market Updates - StockTitan

Mar 14, 2025
pulisher
Mar 13, 2025

Shuttle Pharma Announces Closing Of $5.75 Million Underwritten Offering -March 13, 2025 at 05:39 pm EDT - Marketscreener.com

Mar 13, 2025
pulisher
Mar 13, 2025

Shuttle Pharma Secures $5.2M in Public Offering - TipRanks

Mar 13, 2025
pulisher
Mar 13, 2025

Shuttle Pharma Announces Closing of $5.75 Million Underwritten Offering - GlobeNewswire

Mar 13, 2025
pulisher
Mar 13, 2025

Shuttle Pharma Announces Closing of $5.75 Million Underwritten Offering - Benzinga

Mar 13, 2025
pulisher
Mar 13, 2025

Shuttle Pharma Raises $5.75M: Strategic Boost for Revolutionary Cancer Treatment Trial - StockTitan

Mar 13, 2025
pulisher
Mar 12, 2025

Shuttle Pharma appoints new interim co-CEO By Investing.com - Investing.com Australia

Mar 12, 2025
pulisher
Mar 12, 2025

This Md. biotech wants to get a cancer treatment to patients. It just tapped an industry outsider as co-CEO. - The Business Journals

Mar 12, 2025
pulisher
Mar 12, 2025

12 Health Care Stocks Moving In Wednesday's Intraday Session - Benzinga

Mar 12, 2025
pulisher
Mar 12, 2025

Shuttle Pharma announces $5.75 million stock offering By Investing.com - Investing.com South Africa

Mar 12, 2025
pulisher
Mar 12, 2025

Shuttle Pharma announces $5.75 million stock offering - Investing.com

Mar 12, 2025
pulisher
Mar 12, 2025

Shuttle Pharma Announces Pricing of $5.75 Million Underwritten Offering -March 12, 2025 at 09:25 am EDT - Marketscreener.com

Mar 12, 2025
pulisher
Mar 12, 2025

Shuttle Pharma Announces Pricing of $5.75 Million Underwritten Offering - GlobeNewswire

Mar 12, 2025
pulisher
Mar 12, 2025

Shuttle Pharma Secures Critical $5.75M Funding for Revolutionary Cancer Radiation Therapy - StockTitan

Mar 12, 2025
pulisher
Mar 12, 2025

4 Artificial Intelligence (AI) Stocks Worth Buying in the Tech Sell-Off - The Globe and Mail

Mar 12, 2025
pulisher
Mar 12, 2025

Lucid Group (LCID) Prepares to Sink Into Penny Stock Territory - The Globe and Mail

Mar 12, 2025
pulisher
Mar 12, 2025

1 Large-Cap Stock with Solid Fundamentals and 2 to Avoid - The Globe and Mail

Mar 12, 2025
pulisher
Mar 12, 2025

Shuttle Pharma appoints new interim co-CEO - Investing.com

Mar 12, 2025
pulisher
Mar 12, 2025

Shuttle Pharma Appoints Christopher Cooper as Interim Co-CEO - citybiz

Mar 12, 2025
pulisher
Mar 12, 2025

Shuttle Pharmaceuticals appoints Christopher Cooper as interim Co-CEO - TipRanks

Mar 12, 2025
pulisher
Mar 12, 2025

Shuttle Pharma Announces Appointment Of Christopher Cooper As Interim Co-CEO To Enhance Business Activities - Marketscreener.com

Mar 12, 2025
pulisher
Mar 12, 2025

Shuttle Pharmaceuticals Appoints Christopher Cooper as Co-CEO - TipRanks

Mar 12, 2025
pulisher
Mar 12, 2025

Shuttle Pharma Announces Appointment of Christopher Cooper as Interim Co-CEO to Enhance Business Activities - GlobeNewswire

Mar 12, 2025
pulisher
Mar 12, 2025

Shuttle Pharma Strengthens Leadership: New Co-CEO to Accelerate Growth While Phase 2 Trial Advances - StockTitan

Mar 12, 2025
pulisher
Mar 12, 2025

2 Reasons to Watch GE and 1 to Stay Cautious - The Globe and Mail

Mar 12, 2025
pulisher
Mar 07, 2025

SHPH stock touches 52-week low at $0.5 amid sharp annual decline - Investing.com Australia

Mar 07, 2025
pulisher
Mar 07, 2025

SHPH stock touches 52-week low at $0.5 amid sharp annual decline By Investing.com - Investing.com South Africa

Mar 07, 2025
pulisher
Mar 07, 2025

Zscaler: Bullish Pressure Builds, Rapid Price Increase Expected - The Globe and Mail

Mar 07, 2025
pulisher
Mar 05, 2025

Shuttle Pharmaceuticals Holdings Offers Up To 10,000,000 Shares Of Common Stock -March 05, 2025 at 07:42 am EST - Marketscreener.com

Mar 05, 2025
pulisher
Mar 05, 2025

Amendment: SEC Form S-1/A filed by Shuttle Pharmaceuticals Holdings Inc. - Quantisnow

Mar 05, 2025
pulisher
Feb 28, 2025

Shuttle Pharmaceuticals Enters Revolving Loan Agreement - TipRanks

Feb 28, 2025
pulisher
Feb 28, 2025

Shuttle Pharmaceuticals Holdings Enters $2 Million Revolving Loan Agreement -February 28, 2025 at 05:26 pm EST - Marketscreener.com

Feb 28, 2025
pulisher
Feb 28, 2025

Shuttle Pharmaceuticals Holdings Enters $2 Million Revolving Loan Agreement - TradingView

Feb 28, 2025
pulisher
Feb 28, 2025

3 Reasons to Sell RH and 1 Stock to Buy Instead - The Globe and Mail

Feb 28, 2025
pulisher
Feb 27, 2025

SEC Form 424B3 filed by Shuttle Pharmaceuticals Holdings Inc. - Quantisnow

Feb 27, 2025
pulisher
Feb 27, 2025

Shuttle Pharmaceuticals Amends Agreement with Alto Fund By Investing.com - Investing.com Australia

Feb 27, 2025
pulisher
Feb 27, 2025

Shuttle Pharmaceuticals Amends Agreement with Alto Fund - Investing.com

Feb 27, 2025
pulisher
Feb 26, 2025

SHPH stock touches 52-week low at $0.57 amid market challenges By Investing.com - Investing.com South Africa

Feb 26, 2025
pulisher
Feb 26, 2025

SHPH stock touches 52-week low at $0.57 amid market challenges - Investing.com

Feb 26, 2025
pulisher
Feb 26, 2025

Shuttle Pharma advances glioblastoma trial, expands diagnostics - Investing.com India

Feb 26, 2025
pulisher
Feb 26, 2025

Shuttle Pharma advances glioblastoma trial, expands diagnostics By Investing.com - Investing.com South Africa

Feb 26, 2025
pulisher
Feb 26, 2025

Shuttle Pharmaceuticals Holdings, Inc. Reports Progress on Phase 2 Trial and Diagnostic Advancements in Annual Update - Nasdaq

Feb 26, 2025
pulisher
Feb 26, 2025

Shuttle Pharma Provides Corporate Update and Reports 2024 Results - GlobeNewswire

Feb 26, 2025
pulisher
Feb 26, 2025

Can Shuttle Pharma's Glioblastoma Treatment Breakthrough Deliver Returns? CEO Bets $237K - StockTitan

Feb 26, 2025
pulisher
Feb 26, 2025

Shuttle Pharmaceuticals Holdings, Inc. SEC 10-K Report - TradingView

Feb 26, 2025

Shuttle Pharmaceuticals Holdings Inc Stock (SHPH) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$10.83
price up icon 0.19%
$34.34
price down icon 0.09%
$103.28
price up icon 1.04%
$110.31
price up icon 0.56%
$9.42
price down icon 1.05%
$131.53
price up icon 0.06%
Cap:     |  Volume (24h):